Constellation Brands Q2 FY2027 10-Q: EPS up 25%, tax rate guidance cut to 11-13%, Nelson's Green Brier impairment
STZ is trading near its 52-week low of $110.602 (6.6% above the low) on elevated volume (1.9× avg).
Summary
Constellation Brands filed its Q2 FY2027 10-Q, confirming EPS of $3.32 (up 25% YoY) and adding new disclosures: Fiscal 2027 tax rate guidance cut to 11-13%, a $49.8M impairment on Nelson's Green Brier, and continued share buybacks.
Key Events · Earnings and Guidance · STZ
-
Q2 FY2027 Results Confirmed
Net sales rose 6% to $2,633.0M; net income attributable to CBI rose 21% to $565.8M; diluted EPS rose 25% to $3.32. Operating income fell 8% to $805.0M on higher marketing spend and unfavorable short-term incentive accruals.
-
Tax Rate Guidance Cut
Fiscal 2027 effective tax rate guidance lowered to 11%-13%, including an estimated $100M-$150M income tax benefit from foreign tax reform to be recognized in Q3 FY2027 (quarter ending November 30, 2026).
-
Nelson's Green Brier Impairment
Assets held for sale with a $54.8M carrying value were written down to $5.0M fair value, resulting in a $49.8M net loss included in asset impairment and related expenses for Q2 FY2027.
-
Debt Activity
Entered a new $300M delayed draw term loan facility (2026 Term Credit Agreement) in September 2026; redeemed $600M of 4.35% May 2022 Senior Notes on September 18, 2026.
Analysis · STZ · Manufacturing
The 10-Q confirms the strong Q2 results already reported in the October 6 8-K, but adds material new detail: full GAAP financials, a lowered Fiscal 2027 effective tax rate guidance of 11%-13% driven by a $100M-$150M foreign tax reform benefit, a $49.8M impairment on the planned Nelson's Green Brier divestiture, and updated debt and buyback activity. The tax benefit is a one-time non-cash item that will boost Q3 EPS, while the impairment reflects a write-down of a struggling asset. The stock fell 4.5% after the earnings release, suggesting the market is focused on the higher marketing spend and short-term incentive accruals that pressured operating income despite the EPS beat.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STZ was trading at $117.96 on NYSE in the Manufacturing sector, with a market capitalization of approximately $20.1B. The 52-week trading range was $110.60 to $168.60. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.